3 results
8-K
EX-99.1
ALIM
Alimera Sciences Inc.
31 Mar 23
Alimera Sciences Announces 2022 Financial Results and Business Update
8:43am
Presented:
Confirming the safety and reduced burden of care for diabetic macular edema (DME) patients at the annual American Society of Retina
8-K
ALIM
Alimera Sciences Inc.
25 Aug 11
Other Events
12:00am
Sciences, Inc.’s Phase 3 FAME Study of ILUVIEN in patients with diabetic macular edema at the 29th Annual Meeting of the American Society of Retina
- Prev
- 1
- Next